CompletedNCT00460356
Glycoprotein and Glycan in Tissue and Blood Samples of Patients With Stage IB-IVA Cervical Cancer Undergoing Surgery to Remove Pelvic and Abdominal Lymph Nodes
Studying Adenocarcinoma of the cervix uteri
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Gynecologic Oncology Group
- Principal Investigator
- Michael GoldNRG Oncology
- Intervention
- Laboratory Biomarker Analysis(other)
- Enrollment
- 159 target
- Eligibility
- 18 years · FEMALE
- Timeline
- 2007 – 2016
Study locations (18)
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California, United States
- Olive View-University of California Los Angeles Medical Center, Sylmar, California, United States
- Augusta University Medical Center, Augusta, Georgia, United States
- Wayne State University/Karmanos Cancer Institute, Detroit, Michigan, United States
- Saint Louis University Hospital, St Louis, Missouri, United States
- Sunrise Hospital and Medical Center, Las Vegas, Nevada, United States
- Women's Cancer Center of Nevada, Las Vegas, Nevada, United States
- Montefiore Medical Center-Einstein Campus, The Bronx, New York, United States
- Summa Akron City Hospital/Cooper Cancer Center, Akron, Ohio, United States
- University of Cincinnati/Barrett Cancer Center, Cincinnati, Ohio, United States
- Case Western Reserve University, Cleveland, Ohio, United States
- Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland, Ohio, United States
- Cleveland Clinic Foundation, Cleveland, Ohio, United States
- Hillcrest Hospital Cancer Center, Mayfield Heights, Ohio, United States
- Lake University Ireland Cancer Center, Mentor, Ohio, United States
- +3 more locations on ClinicalTrials.gov
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00460356 on ClinicalTrials.govOther trials for Adenocarcinoma of the cervix uteri
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07276360Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in UgandaUganda Cancer Institute
- RECRUITINGPHASE1NCT07454642AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid TumorsAvacta Life Sciences Ltd
- RECRUITINGPHASE3NCT07061977Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical CancerNational Cancer Institute (NCI)
- RECRUITINGNCT07359586Laryngopharyngeal Injury After Endotracheal Intubation Under General AnesthesiaZhejiang University
- RECRUITINGPHASE1NCT07020117A Study of [225Ac]Ac-AKY-1189 in Patients With Solid TumorsAktis Oncology, Inc.
- RECRUITINGPHASE2NCT06654011IN10018 With Nab-Paclitaxel and Cadonilimab for Metastatic or Recurrent Gastric-Type Cervical Adenocarcinoma: Phase 2 TrialUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT07153952RT for Adenocarcinoma/Adenosquamous CarcinomaPeking Union Medical College Hospital
- RECRUITINGNCT06733740Ultrasound-guided Thermal Ablation for Papillary Thyroid CarcinomaChinese PLA General Hospital